(2024)
A highly conserved tRNA modification contributes to C. albicans filamentation and virulence.
Microbiol Spectr 12(5),
e0425522.
Publications
(2023)
The role of host and fungal factors in the commensal-to-pathogen transition of Candida albicans.
Curr Clin Micro Rpt 10(2),
55-65.
(Review)
(2023)
Mouse models of Mucormycosis.
Methods Mol Biol 2667,
181-196.
(Review)
(2023)
Soluble enolase 1 of Candida albicans and Aspergillus fumigatus stimulates human and mouse B cells and monocytes.
J Immunol 211(5),
804-815.
(2023)
Escherichia coli nissle 1917 antagonizes Candida albicans growth and protects intestinal cells from C. albicans-mediated damage.
Microorganisms 11(8),
1929.
(2023)
Microbiome and immuno-metabolic dysregulation in patients with major depressive disorder with atypical clinical presentation.
Neuropharmacology 235,
109568.
(Review)
(2023)
Metabololipidomic and proteomic profiling reveals aberrant macrophage activation and interrelated immunomodulatory mediator release during aging.
Aging Cell 22(7),
e13856.
(2022)
Systemic Candidiasis in mice: New insights from an old model.
Front Fungal Biol 3,
940884.
(Review)
(2022)
Phagosomal signalling of the C-type lectin receptor Dectin-1 is terminated by intramembrane proteolysis.
Nat Commun 13(1),
1880.
(2022)
Augmented enterocyte damage during Candida albicans and Proteus mirabilis coinfection.
Front Cell Infect Microbiol 12,
866416.